General form of registration statement for all companies including face-amount certificate companies

Note 20 - Revision of Prior Period Financial Statements (Tables)

v3.24.3
Note 20 - Revision of Prior Period Financial Statements (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
   

As of December 31, 2022

 
   

As reported

   

Adjustment

   

As revised

 

Accrued liabilities

    740       115       855  

Total current liabilities

    2,246       115       2,361  

Total liabilities

    2,246       115       2,361  

Accumulated deficit

    (73,906 )     (115 )     (74,021 )

Total shareholders’ deficit

    (2,111 )     (115 )     (2,226 )
   

For the year ended December 31, 2022

 
   

As reported

   

Adjustment

   

As revised

 

Research and development expenses

    1,272       27       1,299  

General and administration expenses

    1,454       88       1,542  

Total operating expenses

    3,329       115       3,444  

Loss before Income Tax

    (3,789 )     (115 )     (3,904 )

Net Loss and Comprehensive Loss

    (3,789 )     (115 )     (3,904 )
   

For the year ended December 31, 2022

 
   

As reported

   

Adjustment

   

As revised

 

Net loss

    (3,789 )     (115 )     (3,904 )

Change in accrued liabilities

    (18 )     115       97  

Net cash used in operating activities

    (2,892 )     -       (2,892 )